TickerTalks
Browse all tickers →
TickerTalks›$CLBT
CLCLBT

Cellebrite DI Ltd.

$CLBT·$2.7B·Software - Infrastructure·Technology
$11.99-2.4%1Y-28.2%
Mentions · last 7 days
2026-08-21: 3 posts2026-08-22: 3 posts2026-08-23: 2 posts52-2%
Price updated 3d ago·X counts updated 7d ago
CLCLBT
$CLBTCellebrite DI Ltd.
$11.99-2.44%52 posts-2%
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Top X posts

Today's AI verdict on what's driving $CLBT, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Comeback attemptSelling offAI verdict · as of 2026-08-31

Falling on heavy selling — points lower unless it turns around.

Cellebrite — Q2 rev +16% and ARR +21% to $508M, but guidance cut, stock down 30% in a week, and Kaplan Fox opened a securities investigation.

Cellebrite is an Israeli digital-intelligence software company serving law enforcement and government forensics — a software franchise where the operating metrics look good in isolation but management execution and a new CEO transition have thrown the tape into a proper break-down.

  • Q2 2026 revenue $131M (+16% YoY) with ARR up 21% to $508M and adjusted EBITDA margin 24% — headline software metrics are still strong on an absolute basis but the Q2 beat streak is deteriorating: last four EPS surprises are -57%, -26%, -38%, -15%, missing consensus every quarter with the miss widening.
  • Full-year guidance was cut and the stock is down 30% in a week — bulls frame the guide-down as new-CEO 'kitchen-sinking' expectations with 4-5 major deals only slipped a quarter and Federal tailwinds ahead, but the print itself was a meaningful miss on the ARR trajectory.
  • Kaplan Fox & Kilsheimer opened a securities-law investigation announced Aug 26 and Aug 28 — plaintiffs-bar investigations after a large drop don't confirm actual wrongdoing but they add legal-overhang cost and headline risk to what is already a broken-momentum name.
  • Insider tape is uniformly selling: Hogan sold 25.3K shares Aug 27 at $11.29, Gee sold two batches Aug 24-25 at $11.24-$11.36, Jewell sold 12.6K Aug 24 at $11.24, more Aug 13 — every recent insider transaction is a sale and stock trades at 23% of 52-week range, so this is not opportunistic selling into strength.

What resolves this upward is Q3 restoring the ARR growth cadence plus the new CEO reiterating the four-to-five 'slipped-not-lost' deals actually closing — that ratifies the kitchen-sink read. What extends the break-down is another ARR miss or the securities investigation surfacing specific disclosure allegations — either turns the pullback into a full re-rate lower.

Agrees with X sentimentThe mixed X take — Q2 rev $131M (+16%), ARR +21% to $508M, 24% adj EBITDA margin, bull note framing as new-CEO 'kitchen-sinking' with 4-5 slipped deals and Federal tailwinds ahead, bears citing 30% drop and full-year cut, chartists wanting 0.786 fib to hold — captures the real split-view on this broken-momentum-with-turnaround-optionality setup.

What to watch: Q3 restoring ARR growth cadence plus the new CEO reiterating the 'slipped-not-lost' deals closing resolves this upward; another ARR miss or the securities investigation surfacing specific allegations turns the pullback into a full re-rate lower.

On the calendar: 2026-11-11 — Q3 2026 earnings

X sentiment

What the X crowd is saying right now — descriptive, summarised from the day’s posts.

Mixed sentiment5 posts analyzed · as of 2026-08-21

Sentiment on Cellebrite is split. On the positive side Q2 delivered revenue of $131M (+16%), ARR +21% to $508M, adj EBITDA margin 24%, robust FCF, and the bull note frames the guidance cut as 'kitchen-sinking' expectations for the new CEO with 4-5 major deals only slipped a quarter and Federal tailwinds ahead. Bears counter that the ARR shortfall and full-year cut are real, the stock is down 30% in a week, and the valuation still isn't screaming cheap. Chartists want the 0.786 fib to hold before adding.

Read the AI verdict + X sentiment for $CLBT

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Digital intelligence platform enabling law enforcement to collect, analyze, and manage evidence from mobile devices and digital sources.

Industry overviewAI analysisGenerated by AI from underlying data

Where Software - Infrastructure sits in its cycle right now — and what that implies for $CLBT.

Software - Infrastructure · Technology

SaaS multiples remain compressed as rate-sensitive valuations weigh on pure-play software; customers are lengthening deal cycles outside of AI-native workloads. AI co-pilot upsell is the only clear near-term catalyst — companies without it are treading water.

What this means for $CLBT

Direct beneficiary — business directly tied to crypto market cap and adoption cycle; Digital intelligence platform enabling law enforcement to collect, analyze, and .

Top industry ETF

$IGViShares Expanded Tech-Software Sector ETF
-4.2%YTD
+0.4%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
37.0How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
8.8%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
12.8%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
5.7%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
5.4Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
15.5%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
83.9%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.0Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Aug 13, 2026$0.03$0.06-56.7%
Q1 2026May 14, 2026$0.04$0.05-25.6%
Q4 2025Feb 11, 2026$0.09$0.14-38.1%
Q3 2025Nov 12, 2025$0.08$0.09-15.3%
Next earningsWed, Nov 11·consensus EPS $0.17

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$128.3M+19.3%82.5%7.1%$0.04$16.8M
Q4 FY25$128.8M+18.1%84.7%16.2%$0.09$78.3M
Q3 FY25$126.0M+17.9%83.9%15.1%$0.08$29.9M
Q2 FY25$113.3M+18.3%84.4%12.7%$0.08$29.0M

Forward consensus

4-year forecast · up to 6 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$568.0M$566.7M – $569.2M$0.33$0.31 – $0.346
FY27$667.3M$653.8M – $679.6M$0.44$0.41 – $0.476
FY28$783.2M$757.0M – $813.9M$0.57$0.54 – $0.603
FY29$864.7M$852.0M – $880.5M$0.91$0.89 – $0.931

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.4×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.23%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-15.0%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.-19.2%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatMid float · 123.5M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today1.2% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β1.185-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

SellAug 25Thomas E. HoganAdvisor25.3K sh$286KSellAug 24Gee David NicholasChief Marketing Officer4.3K sh$49KSellAug 21Marcus JewellGlobal Chief Revenue Officer12.6K sh$141KSellAug 21Gee David NicholasChief Marketing Officer2.2K sh$25KSellAug 12Thomas E. HoganCEO139.7K sh$2.1MSellAug 12Marcus JewellGlobal Chief Revenue Officer411 sh$7KSellAug 12Gee David NicholasChief Marketing Officer230 sh$4KSellJul 8David BarterCFO41.7K sh$683KSellJul 2Thomas E. HoganCEO103.2K sh$1.6MSellMay 21Gee David NicholasChief Marketing Officer5.7K sh$74K
1–10 of 13
+ 2 other (2 awards) in window

See when $CLBT insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

3New insider — initial holdingsMay 73
3New insider — initial holdingsMar 183
3New insider — initial holdingsMar 183
3New insider — initial holdingsMar 183
3New insider — initial holdingsMar 183
3New insider — initial holdingsMar 183
3New insider — initial holdingsMar 183
3New insider — initial holdingsMar 183
+ 16 other (10 3s · 5 6-Ks · 1 13G) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Kaplan Fox Reminds Cellebrite DI Ltd. (CLBT) Investors of an Investigation into Potential Securities Law Violationsnewsfilecorp.com·3d agoCellebrite stellt den Streitkräften mit der Einführung des «Portable Tactical Extraction Kit» (C-TEK) Informationen aus dem Einsatzgebiet zur Verfügungprnewswire.com·5d agoCellebrite met ses capacités de renseignement sur le champ de bataille au service des forces armées avec le lancement du Portable Tactical Extraction Kit (C-TEK)prnewswire.com·5d agoKaplan Fox & Kilsheimer LLP Alerts Investors of Cellebrite DI Ltd. (CLBT) to an Investigation of Potential Securities Law Violationsnewsfilecorp.com·5d agoCellebrite Brings Battlefield Intelligence to the Armed Forces with Launch of Portable Tactical Extraction Kit (C-TEK)prnewswire.com·5d ago

More in Software - Infrastructure

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$NET$NBIS$MSFT$PLTR$CRWV$ORCL$XYZ$CRWD
Voices on X · top 2 · last 7 days

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport